Industry advocates are lobbying the U.S. Food and Drug Administration to allow spices to bear the label "healthy" under its nutritional guidelines.
Independent advisors Wednesday, recommended the U.S. Food and Drug Administration approve over the counter sales of naloxone, which is commonly used to reverse opioid overdoses.
New research suggests it could be possible to disrupt the inflammation that causes multiple sclerosis by blocking a specific cell receptor.
Alternate-day fasting, combined with exercise, may help improve the health of patients with nonalcoholic fatty liver disease, researchers say.
A new study provides more evidence that diets high in free sugars, found in processed foods and sodas, increase the risk of heart disease and stroke.
An experimental new male birth control drug is able to take effect within 30 minutes in lab mice studies.
A California-based company is recalling male enhancement pills over concerns the gel capsules contain two unauthorized prescription medications, the U.S. Food and Drug Administration confirmed Tuesday.
Researchers have developed a new method to detect early signs of Parkinson's disease by monitoring movements of patients using available wearable technology like Apple Watches and Fitbits.
A study published in the JAMA Network Open on Tuesday reveals insight into long-term effects of COVID-19 on individuals infected during the Omicron wave, suggesting they face an elevated risk of diabetes.
A new study by the University of Southern California revealed that those who regularly vape and smoke suffer the same levels of DNA damage, refuting messages about vaping being a safer alternative to smoking.
Researchers in New York have revealed a new way in which cannabidiol, or CBD, reduces seizures in children who suffer from a variety of treatment-resistant forms of epilepsy.
Frequency Therapeutics announced it will scrap development of a drug called FX-322 after testing failed to show improvement in speech perception in people with noise-induced sensorineural hearing loss.
People who have been diagnosed with COVID-19 may be 66% more likely to develop type 1 or type 2 diabetes, a study at Penn State College of Medicine says.
U.S. Surgeon General Dr. Vivek Murthy on Saturday urged state governments to tackle the youth mental crisis by investing in treatment, expanding their mental health work forces and reducing stigma.
As little as a cup a day of strawberries can improve heart health, according to the Global Burden of Disease study.
A new study finds toddlers' attention to high-pitched, sing-songy speech -- or "baby talk" -- could provide an early diagnosis and treatment of autism spectrum disorder.
Researchers at Boston University have identified chronic traumatic encephalopathy in the brains of more than 91% of former NFL players involved in an ongoing study of the delayed neurodegenerative disorder.
The sentiment toward smoking has drastically changed and a survey by the Centers for Disease Control and Prevention indicates most Americans are ready to end the sale of tobacco products.
Nearly half of American women report taking days off from work due to menstrual symptoms, according to a new study that found digital health apps could help workplace productivity.
Eating more ultra-processed foods -- such as cookies, chips and sodas -- may be linked to a higher risk of developing and dying from cancer, a new study says.
A new study shows there are seven long-term health symptoms that are directly related to long-COVID-19, giving researchers a better understanding of how the virus that causes COVID-19 may mutate or evolve.
The number of tobacco products sold in the U.S. market is off its peak, though recent data show menthol cigarettes are increasingly popular and smoking among kids is on the rise.
The People's Republic of China will again grant visas to Japanese citizens after a pause earlier this month.
The U.S. Food and Drug Administration Friday proposed loosening restrictions based on gender and sexual orientation for blood donors in the United States.
The Food and Drug Administration on Thursday withdrew emergency use authorization for the COVID-19 drug Evusheld because of its lack of effectiveness against some of the more widespread coronavirus variants.